News & Events

Vivli team to speak at National Academies Meeting on sharing clinical trial data

Challenges and a Way Forward in Sharing Clinical Trial Data: A Workshop on November 18-19, 2019

Vivli Executive Director, Rebecca Li, will speak about the Vivli platform on the first day and Vivli founder and technical lead, Ida Sim, will moderate a session on the second day about Overcoming Usability and Sustainability Challenges.

The workshop will explore challenges, and opportunities in clinical trial data sharing efforts since the release of the 2015 Institute of Medicine report Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk.

WORKSHOP SPEAKERS WILL:

  • Consider the value and the potential risks/costs of sharing clinical trial data for key stakeholders, including clinical trialists, sponsors, primary and secondary researchers, and patients;
  • Review the current landscape of clinical trial data sharing and reuse across public and private sectors (e.g., policies, platforms, collaborations, data sharing culture, published research output);
  • Examine use cases and trends from across public and private sectors when it comes to success, failure, lessons learned, and value;
  • Consider the perspectives and expectations of primary and secondary researchers, clinical trial participants, patient organizations, research sponsors (pharmaceutical companies and nonprofit organizations), journals, institutions, and federal agencies; and
  • Discuss next step opportunities for stakeholders to better harmonize incentives, policy, data standards, and governance to encourage the sharing and reuse of clinical trial data.

This workshop is co-sponsored by the Wellcome Trust and convened under the auspices of the National Academies Forum on Drug Discovery, Development, and Translation; the Forum on Neuroscience and Nervous System Disorders; the National Cancer Policy Forum; and the Roundtable on Genomics and Precision Health.

Credit for Data Sharing Webinar

Vivli, the Multi-Regional Clinical Trials Center (MRCT Center) and Association of American Medical Colleges (AAMC) present a discussion on methodologies for appropriating credit in data sharing. Dr. Barbara Bierer, MRCT Center Faculty Director, and Heather Pierce, Senior Director of Science Policy for AAMC share how purpose-driven data sharing both enhances scientific discovery and ensures data generators receive credit for their work. The webinar will be held Tuesday, November 12th at 11am EST.

Topics include:
• Methods for leveraging existing initiatives to track, use, and reuse impactful scientific data
• Benefits of purpose-driven data sharing to both public and scientific community
• Recommended policy and practice changes
• Role of journals, funders, and academic institutions

RECORDING

Presenters
Barbara E. Bierer, MD
Faculty Director, the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard (MRCT Center)
Co-Founder and Board Member, Vivli
Heather Pierce, JD, MPH
Senior Director – Science Policy, Regulatory Counsel, Scientific Affairs. Association of American Medical Colleges

Li discusses datathon outcomes at RWE workshop

Vivli Executive Director Rebecca will present at the Drug Information Association’s (DIA) Future of Evidence Workshop session on Real World Evidence (RWE), Data Sharing and Data Transparency. Dr. Li’s presentation on “Finding New Solutions to Problems and Concerns in Clinical Data Sharing – Outcomes from Datathon” will speak on October 25. The Switzerland based event runs October 24 – October 25, 2019 from 9:00am – 5:30pm. The workshop agenda includes three separate sessions on the important components in maximizing clinical utility, and the role of willingness to share data in this initiative.

Johnson & Johnson joins Vivli as a member

“We are delighted to have Johnson & Johnson join Vivli as a member,” said Rebecca Li, Vivli Executive Director. “This partnership will drive science forward by enabling the combination of J&J data with sources available from Vivli’s other member organizations.”

Read more about the partnership in this post by Joanne Waldstreicher, Chief Medical Officer at Johnson & Johnson.

 

Watch the recording of Vivli’s Annual Meeting

The Vivli Annual Meeting event on Wednesday, September 18, 2019 was recorded.

For those who are unable to attend the meeting in person, you can view the proceedings.

Annual Meeting Agenda

Welcome remarks

Vivli Update for 2019 and Vision for 2020

Working lunch

Invited Speaker: Informed consent and secondary use of data for data sharing – David Peloquin, Ropes & Gray

Panel Discussion: Challenges of sharing small datasets and rare disease data

  • Patrick Cullinan, Takeda
  • Edith Eby, Pfizer
  • Robyn Himick, Amyloidosis Research Consortium
  • David Peloquin, Ropes & Gray
  • Susan Ward, cTAP

Lightning Rounds–Brief updates from Vivli stakeholders

  • Tianjing Li, Johns Hopkins University – Meta-analysis Utilizing IPD
  • Quan Chen, ImmPort, NIH – Data reuse partner
  • Gaurav Luthria and Qingbo Wang, Harvard University – Vivli Microsoft 2019 Datathon Grand Prize Winners
  • Heather Pierce and Anurupa Dev, Association of American Medical Colleges – Credit for data sharing
  • Pam Miller, New England Journal of Medicine – NEJM Experience with Data-Sharing Statements

Wrap-up and Next steps

Vivli Executive Director to Share Experience with Synthetic Data

Dr. Rebecca Li will discuss how Vivli used synthetic datasets as part of its data challenge with Microsoft on a webinar entitled An Introduction to Synthetic Clinical Trial Data. The webinar will be on October 4 at 11am-12pm EDT and is hosted by Replica Analytics. Sign up to the webinar today to find more about how synthetic data can be used to share clinical trial date while protecting participant privacy.

Winners announced for Vivli Microsoft Data Challenge

More than 60 participants forming 11 teams, took part in the first Vivli Microsoft Data Challenge today at District Hall in Boston. Participants were from universities including Harvard, Northeastern, Brown, and Boston as well as nearby hospitals, pharmaceutical, biotech and software companies.

The data challenge focused on finding innovative solutions for how to safeguard participant privacy and minimize privacy loss while maintaining the scientific analytic value of the data for rare disease data sets that are more highly identifiable.

The day started off with a presentation by patient advocate Jane Perlmutter sharing with the attendees the importance of this challenge.

“I’m a long-term cancer survivor… patients don’t have the luxury of patience, she said. “When they enter a clinical trial, they’re hoping they would profit form it, hoping future generations won’t have to suffer from it as well.”  

The teams had one hour to plan and then four hours to come up with their solutions. They were then given five minutes to present their ideas to the judges.

“The Datathon has met our expectations, there’s a really diverse group of people that are rallying around solving a problem,” Paul Slater, co-founder of the Clinical Research Innovation Hub at Microsoft. “They’re discovering, there’s a bunch of innovative approaches to this, we don’t know if we’re getting an end solution but we may certainly get ourselves closer to it. This might be an opportunity to blend some of the best ideas together to make some meaningful products. The thing we’re going after is high impact.”

The winners are:

Global Grand Prize Winner: 

Team: DBMI

Participants: Gaurav Luthria and Qingbo Wang, Harvard University

Most Innovative Solution:

Team: DataHack

Participants: Cynthia Frommit (IND), Het Patel (Beth Israel), Vikas Gaikwad (Plural Point), Luther Evans (MGH Martinos Center), Annadoir Stavely (Otsuka USA) and Vikramen Karunanidhi (Ayu Devices)

Most Outstanding Graduate Submission:

Team: SAIL

Participants: Megan Fantes, Kinan Dak Albab, Wyatt Howe, Yi Zhang, Peter Flockhart, Lucy Qin from Boston University

Outstanding Remote Submission:

Team: Next Tech Lab

Participants: Sourva Sharan, Arjun Bahuguna from Next Tech Lab

Find out more about the Datathon and see the full list of Datathon submissions. 

 

Vivli and Microsoft to host Innovation Challenge on June 21 focusing on sharing rare disease data sets

Join us to find solutions to problems in data privacy and rare disease clinical data sharing and network with tech and medical leaders in the field

Datathon in Boston; free attendance; monetary prizes

WHAT: Microsoft and Vivli, a clinical trial data sharing platform, are joining forces for a one-day datathon in Boston on data privacy and rare disease clinical trial sharing. Rare disease clinical trials often have just a few participants and protecting their privacy and their data is paramount.  But many individuals with rare diseases and their families are eager to have their data shared in order to make progress on their disease and save lives.  How do we solve this?

The problem statement: How can teams safeguard participant privacy and minimize privacy loss while maintaining the scientific analytic value of the data, for smaller data sets or rare disease data set that are more highly identifiable?

WHEN: June 21, Boston’s District Hall, from 10:30 am to 7 pm.  Meals provided!

WHY: This is a great opportunity to network with leaders in this field from Microsoft representatives to leading scientists in the field. Prior experience is not a requirement, attendance is free, and monetary prizes for the top winning solutions chosen by judges.

PRIZES

The Global Microsoft-Vivli Datathon prize will go to members from the winning team with the highest score. They will receive $1,500 and an invitation and travel expenses paid (up to $1,500 for two team members) to Vivli’s Annual Meeting in Washington, DC. The team will be invited to present their solution to stakeholders in the data sharing community (non-profit foundations, pharmaceutical industry and leading academic institutions). Additional prizes:

$500: Most Innovative Solution

$200: Most Outstanding Graduate Submission—submission from a team comprised of a majority of graduate students

$200: Most Outstanding Undergraduate Submission — submission from a team comprised of a majority of undergraduate students

Outstanding Remote submission — A select group of remote, international participants will be admitted, but are not eligible for the other prizes

Read the FAQs for more information about the event, including ideas that could be included in your team’s submission to the innovation challenge.

WHO: Individuals or teams from all backgrounds, skills, genders, and geographies are welcome. We accept a wide range of applicants, from beginners, to experienced veterans of innovation challenges. Invited are all experts and leaders in data analytics, data science, technology, clinical research, patient advocacy, data privacy and statistics.

Rules

Agenda 

FAQs

Sponsors 

Questions? support@vivli.org

 

 

Informed Consent and Data Sharing — A community conversation

Informed Consent and Data Sharing – a community discussion from

Vivli is pleased to provide a recording of our latest presentation, a discussion with leading experts in informed consent and data sharing. This conversation, recorded live February 13, 2019, featured Vivli Executive Director Rebecca Li, Dr. Barbara Bierer, Faculty Director of the MRCT Center, David Peloquin, Associate at Ropes & Gray, and Dr. Stephen Rosenfeld, SACHRP Committee Chair, discussing informed consent and data sharing.  

Watch Now

Topics include: 

  • Prospectively what makes broad consent sufficient? What are the limits? 
  • Retrospectively what elements preclude consent? 
  • ICF template language for data sharing 
  • GDPR / other international regulations and informed consent 

Presenter bios: 

Dr. Barbara Bierer 

Faculty Director, MRCT Center   

Dr. Rebecca Li 

Executive Director, Vivli  

Mr. David Peloquin 

Associate, Ropes and Gray 

Dr. Stephen Rosenfeld 

IRB/REB Chair, Quorum; Chair, SACHRP 

 

 

 

 

 

 

 

Vivli 2018 Progress Report

We are delighted to share with you Vivli’s 2018 Progress Report

Vivli would not be here today if it was not for the aid, support and encouragement of all of you. We look forward to continuing to grow together in 2019 and beyond, as leaders in data sharing and transparency, working together towards our shared goals of improving human health.